CAS: 137219-37-5
All products are only used for scientific research, instead of human or animal experiments.
Cat. No.:HD00053
Formula:C57H87N7O15
Mol. Weight:1110.34
Purity:≥98%
Long Term Storage:Store in a tight container at -20°C.
Description:A Repurposed Drug for the Treatment of COVID-19;Antitumor
Size | Price, EXW | Stock | Quantity | Add to Cart |
---|---|---|---|---|
1mg | $798.00 | In stock | - 1 + | |
10mg | $1580.00 | In stock | - 1 + | |
50mg | $5980.00 | In stock | - 1 + | |
100mg | Inquiry | In stock | - 1 + |
[1] Pardanani A, Tefferi A, Guglielmelli P, Bogani C, Bartalucci N, Rodríguez J, Extremera S, Pérez I, Alfaro V, Vannucchi AM. Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial. Blood Cancer J. 2015 Mar 13;5:e286.
[2] Lollo G, Hervella P, Calvo P, Avilés P, Guillén MJ, Garcia-Fuentes M, Alonso MJ, Torres D. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative. Int J Pharm. 2015 Apr 10;483(1-2):212-9.
[3] Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. José F. Varona,et al. doi: https://doi.org/10.1101/2021.05.25.21257505.
You are the 1621769 th Visitor
Phone:0086-571-86907218
Email:hdcsales@huidacollection.cn
Copyright © 2021 HuiDaCollection 浙ICP备20008217号 Designed by Wanhu